RESMED INC. COMMON STOCK

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

15 Mar 2024 02:05:00 By Nasdaq GlobeNewswire

Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask

06 Mar 2024 08:05:00 By Nasdaq GlobeNewswire

ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea

12 Feb 2024 15:16:33 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024

24 Jan 2024 15:05:01 By Nasdaq GlobeNewswire

ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024

03 Jan 2024 15:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

27 Dec 2023 15:05:00 By Nasdaq GlobeNewswire

ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices

20 Dec 2023 15:05:00 By Nasdaq GlobeNewswire

ResMed Secures Significant Victory in Patent Fight Against New York University

11 Dec 2023 15:05:00 By Nasdaq GlobeNewswire

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

07 Dec 2023 14:34:58 By Nasdaq GlobeNewswire

ResMed Adopts New Operating Model to Accelerate Long-term Growth

09 Nov 2023 15:05:02 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024

26 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023

05 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in Upcoming Conferences

05 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023

03 Aug 2023 15:05:02 By Nasdaq GlobeNewswire

ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023

06 Jul 2023 15:05:00 By Nasdaq GlobeNewswire

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

05 Jul 2023 15:05:00 By Nasdaq GlobeNewswire

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

08 Jun 2023 08:00:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference

05 Jun 2023 15:05:00 By Nasdaq GlobeNewswire

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

25 May 2023 08:00:01 By Nasdaq GlobeNewswire

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer

02 May 2023 15:05:00 By Nasdaq GlobeNewswire